eye, with Scer\GAL4ey.PH
Expression of EP1350EP1350 under the control of Scer\GAL4ey.PH strongly reduces the eye size.
Scer\GAL4ey.PH/EP1350EP1350 is an enhancer of visible | dominant phenotype of L2
Scer\GAL4pnr-MD237/EP1350EP1350 is an enhancer of visible phenotype of pnrMD237
EP1350EP1350, L2/L[+], Scer\GAL4ey.PH has lethal | pupal stage phenotype
EP1350EP1350, L2, Scer\GAL4ey.PH has lethal | pupal stage phenotype
Scer\GAL4ey.PH/EP1350EP1350 is an enhancer of eye phenotype of L2
EP1350EP1350, Scer\GAL4pnr-MD237, pnrMD237/pnr[+] has scutellum phenotype
EP1350EP1350, Scer\GAL4pnr-MD237, pnrMD237 has scutellum phenotype
L2/+ pharate adults expressing EP1350EP1350 under the control of Scer\GAL4ey.PH have a no eye phenotype, but the antennal field is not affected.
pnrMD237/+ adults expressing EP1350EP1350 under the control of Scer\GAL4pnr-MD237 have a deformed scutellum.
Selected as: a P{EP} insertion line that modifies the pnrMD237/+ phenotype when expressed using Scer\GAL4pnr-MD237.